Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid).

Esposito S, Bonanni P, Maggi S, Tan L, Ansaldi F, Lopalco PL, Dagan R, Michel JP, van Damme P, Gaillat J, Prymula R, Vesikari T, Mussini C, Frank U, Osterhaus A, Celentano LP, Rossi M, Guercio V, Gavazzi G.

Hum Vaccin Immunother. 2016 Jul 2;12(7):1777-94. doi: 10.1080/21645515.2016.1150396. Epub 2016 May 2.

PMID:
27135390
2.
3.

Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness.

Omer SB, Phadke VK, Bednarczyk RA, Chamberlain AT, Brosseau JL, Orenstein WA.

J Infect Dis. 2016 Apr 15;213(8):1216-23. doi: 10.1093/infdis/jiv457. Epub 2015 Oct 28.

PMID:
26516141
4.

Kaiser Permanente Vaccine Study Center: Highlights of 2009-2012.

Baxter R, Klein NP.

Vaccines (Basel). 2013 Apr 25;1(2):139-53. doi: 10.3390/vaccines1020139. Review.

5.

Association between monovalent influenza A (H1N1) pdm09 vaccine and pneumonia among the elderly in the 2009-2010 season in Japan: A case-control study.

Kondo K, Suzuki K, Washio M, Ohfuji S, Fukushima W, Maeda A, Hirota Y; Pneumonia in Elderly People Study Group.

Hum Vaccin Immunother. 2015;11(5):1088-93. doi: 10.1080/21645515.2015.1016668. Erratum in: Hum Vaccin Immunother. 2015;11(10):2510.

6.

Controlling Time-Dependent Confounding by Health Status and Frailty: Restriction Versus Statistical Adjustment.

McGrath LJ, Ellis AR, Brookhart MA.

Am J Epidemiol. 2015 Jul 1;182(1):17-25. doi: 10.1093/aje/kwu485. Epub 2015 Apr 12.

7.

Why We Should Not Be Indifferent to Specification Choices for Difference-in-Differences.

Ryan AM, Burgess JF Jr, Dimick JB.

Health Serv Res. 2015 Aug;50(4):1211-35. doi: 10.1111/1475-6773.12270. Epub 2014 Dec 11.

8.

Influenza vaccine effectiveness assessment through sentinel virological data in three post-pandemic seasons.

Torner N, Martínez A, Basile L, Marcos MA, Antón A, Mar Mosquera M, Isanta R, Cabezas C, Jané M, Domínguez A, Program Of Catalonia TP.

Hum Vaccin Immunother. 2015;11(1):225-30. doi: 10.4161/hv.36155. Epub 2014 Nov 1.

9.

The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012.

Turner N, Pierse N, Bissielo A, Huang QS, Baker MG, Widdowson MA, Kelly H; SHIVERS investigation team.

Vaccine. 2014 Jun 17;32(29):3687-93. doi: 10.1016/j.vaccine.2014.04.013. Epub 2014 Apr 24.

10.

The temporal trend of influenza-associated morbidity and the impact of early appearance of antigenic drifted strains in a Southeast Asian country.

Lian IeB, Wu HD, Chang WT, Chao DY.

PLoS One. 2014 Jan 8;9(1):e84239. doi: 10.1371/journal.pone.0084239. eCollection 2014.

11.

Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥ 65 years: estimates with generalized linear models accounting for healthy vaccinee effects.

Ridenhour BJ, Campitelli MA, Kwong JC, Rosella LC, Armstrong BG, Mangtani P, Calzavara AJ, Shay DK.

PLoS One. 2013 Oct 16;8(10):e76318. doi: 10.1371/journal.pone.0076318. eCollection 2013.

12.

Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season.

Kwong JC, Campitelli MA, Gubbay JB, Peci A, Winter AL, Olsha R, Turner R, Rosella LC, Crowcroft NS.

Clin Infect Dis. 2013 Sep;57(6):820-7. doi: 10.1093/cid/cit404. Epub 2013 Jun 20.

13.

Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.

Reber AJ, Chirkova T, Kim JH, Cao W, Biber R, Shay DK, Sambhara S.

Aging Dis. 2012 Feb;3(1):68-90. Epub 2011 Sep 30.

14.

Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment.

McGrath LJ, Kshirsagar AV, Cole SR, Wang L, Weber DJ, Stürmer T, Brookhart MA.

Arch Intern Med. 2012 Apr 9;172(7):548-54. doi: 10.1001/archinternmed.2011.2238.

15.

The human side of influenza.

Oshansky CM, Thomas PG.

J Leukoc Biol. 2012 Jul;92(1):83-96. doi: 10.1189/jlb.1011506. Epub 2012 Feb 23. Review.

16.

Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study.

Steens A, Wijnans EG, Dieleman JP, Sturkenboom MC, van der Sande MA, van der Hoek W.

BMC Infect Dis. 2011 Jul 18;11:196. doi: 10.1186/1471-2334-11-196.

17.

Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France.

Pelat C, Falchi A, Carrat F, Mosnier A, Bonmarin I, Turbelin C, Vaux S, van der Werf S, Cohen JM, Lina B, Blanchon T, Hanslik T.

PLoS One. 2011 May 10;6(5):e19621. doi: 10.1371/journal.pone.0019621.

18.

Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults.

Talbot HK, Griffin MR, Chen Q, Zhu Y, Williams JV, Edwards KM.

J Infect Dis. 2011 Feb 15;203(4):500-8. doi: 10.1093/infdis/jiq076. Epub 2011 Jan 10.

Items per page

Supplemental Content

Write to the Help Desk